FDA Authorizes First At-Home Sample Collection Test for COVID-19
WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.
The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.
The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.
Before gaining access to the home test, people are screened using an online questionnaire.
If authorized by a physician, LabCorp will ship a testing kit to their home.
The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.
The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.
FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”
“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.
“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.
The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.
In The News
AUSTIN, Texas – It was a dire situation that Lloyd Armbrust can almost laugh about now. A global pandemic had swept across the United States, a baby was on the way, and Armbrust, hard as he tried, could not find a supply of a critical element... Read More
WASHINGTON (AP) — President Joe Biden and Democrats agreed to tighten eligibility limits for stimulus checks, bowing to party moderates as leaders prepared to move their $1.9 trillion COVID-19 relief bill through the Senate. At the same time, the White House and top Democrats stood by... Read More
WASHINGTON (AP) — President Joe Biden urged Senate Democrats to rally behind a $1.9 trillion COVID-19 relief bill and stood by his proposed $1,400 payments to individuals, even as some party moderates sought to dial back parts of the package."He said we need to pass this... Read More
Pharmceutical giant Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House announcedTuesday. The partnership will help advance the administration's goal of speeding up production of the single-dose vaccine and accelerate... Read More
LUBBOCK, Texas – Texas Gov. Greg Abbott rescinded the state’s face mask mandate Tuesday afternoon, declaring that it’s time for Texans to get back to business. “Under no circumstance can someone be punished for not wearing a mask,” Abbott said as he was surrounded by local... Read More
WASHINGTON - It’s hard to believe it’s almost that time of year again, but on Monday came word that the peak bloom for the cherry blossoms ringing the Tidal Basin in Washington is currently expected to occur April 2-5. That means the most vivid of blooms... Read More